In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bernie Sanders Urges DoJ To Take Action On Price-Fixing Claims

Executive Summary

Bernie Sanders and Elijah Cummings have written to the DoJ urging strict action against all generic drug manufacturing companies accused of a price-fixing conspiracy.

You may also be interested in...



Sanders Maintains The Pressure On Teva, Mylan and Heritage

After urging the US DoJ to act against pharma companies alleged to have conspired in a price-fixing conspiracy, Bernie Sanders and Elijah Cummings write letters to Teva, Mylan and Heritage, accusing the companies of obstructing their enquiry.

Unsealed Price-Fixing Complaint Reveals Emails

Emails between major generics firms including Teva, Sandoz and Mylan have been revealed after a court unsealed a complaint filed by 44 US states claiming widespread price-fixing among numerous industry players.

Heritage Clarifies No Guilty Plea In US Settlement

Heritage has clarified that its recent settlement deal with the US Department of Justice over price-fixing allegations did not include the company entering a guilty plea.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

SC027449

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel